DXB 3.06% 47.5¢ dimerix limited

Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-171

  1. 1,566 Posts.
    lightbulb Created with Sketch. 409
    Still may be attractive to big pharma even with today's results - could mean they could negotiate a better deal now
    rather than later. After all it does work on the people who need it most! People who are not prepared for a setback
    in results should not invest in share market. Nothing is guaranteed especially in 2020.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
47.5¢
Change
-0.015(3.06%)
Mkt cap ! $261.3M
Open High Low Value Volume
49.5¢ 49.5¢ 46.5¢ $2.742M 5.746M

Buyers (Bids)

No. Vol. Price($)
3 158396 47.5¢
 

Sellers (Offers)

Price($) Vol. No.
48.0¢ 162500 2
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.